Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Receivables (2019 - 2025)

Volitionrx (VNRX) has disclosed Receivables for 8 consecutive years, with $309085.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Receivables fell 1.13% year-over-year to $309085.0, compared with a TTM value of $309085.0 through Sep 2025, down 1.13%, and an annual FY2024 reading of $110574.0, down 54.42% over the prior year.
  • Receivables was $309085.0 for Q3 2025 at Volitionrx, up from $189597.0 in the prior quarter.
  • Across five years, Receivables topped out at $312611.0 in Q3 2024 and bottomed at $5492.0 in Q3 2022.
  • Average Receivables over 5 years is $116984.4, with a median of $110574.0 recorded in 2024.
  • The sharpest move saw Receivables soared 5783.47% in 2021, then crashed 71.93% in 2022.
  • Year by year, Receivables stood at $12510.0 in 2021, then soared by 480.41% to $72609.0 in 2022, then skyrocketed by 234.14% to $242617.0 in 2023, then plummeted by 54.42% to $110574.0 in 2024, then soared by 179.53% to $309085.0 in 2025.
  • Business Quant data shows Receivables for VNRX at $309085.0 in Q3 2025, $189597.0 in Q2 2025, and $187830.0 in Q1 2025.